Obesity Trial, Recruiting NCT07448090 Sponsor: Hubei Hospital of Traditional Chinese Medicine Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07448090
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older, of any gender
  • People whose weight has stayed relatively stable (changed by no more than 5%) over the past 3 months, and whose body mass index (BMI) is 28.0 or higher
  • People who are willing to attend follow-up appointments and follow the study guidelines
  • People who are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • People who have serious existing conditions affecting the heart, liver, lungs, kidneys, brain, blood, mental health, or other vital organs
  • People whose obesity is caused by another diagnosed medical condition, such as a thyroid disorder, hormonal condition, polycystic ovary syndrome, Cushing's syndrome, or a problem involving the brain's hormone-regulating areas
  • People whose weight gain was caused by medications or medical treatments taken for another condition
  • People who are pregnant or currently breastfeeding
  • People whom the trial team considers unsuitable for participation for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: ChenGang ChenGang, Doctor, Hubei College of Traditional Chinese Medicine

Phone: +86 17720376888

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hubei Hospital of Traditional Chinese Medicine
Registry
ClinicalTrials.gov
Start date
31 August 2024
Est. completion
31 July 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Percentage reduction in body weight relative to baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov